Beth Israel Deaconess Medical Center, Boston
Review examines agents and detectors for stem cell tracking during trials
Published in Cardiovascular Business Week, February 1st, 2005
According to the report from the United States, "Various stem cells hold promise for the treatment of human cardiovascular disease. Regardless of stem cell origin, future clinical trials will require that the location and number of such cells be tracked in vivo, over long periods of time. The problem of tracking small numbers of cells in the body is a difficult one, and an optimal solution does not yet exist."
J.V. Frangioni and colleagues of Beth Israel Deaconess Medical Center said of their report, "We review the many contrast agents and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Abiomed, Inc.
Clinical education, service program is designed to improve recovery - Deltex Medical Group, plc
CardioQ maker provides trading update - Endologix, Inc.
Companies sign development agreement for BioFoam - Finance
CompuMed reports 27% drop in losses - Genentech, Inc.
Company finalizes Avastin label with previously announced safety information - MedicalCV, Inc.
Device manufacturer continues focus on atrial fibrillation procedure - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
